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Abstract
Objective: To analyze the composition of formulations of probiotics sold in establishments 
in the State of Tabasco or that can be purchased online.
Materials and methods: A descriptive study in which formulations of probiotics sold 
in 21 establishments in the city of Villahermosa were identified and compared with 30 
probiotic supplements sold online. Product information was organized in a database and 
analyzed according to the dosage form, probiotic genera, species/subspecies contained and 
their classification as probiotics or synbiotics and as drugs or supplements.
Results: Thirty-one local products and 30 online products formulated with probiotics in 6 
different dosage forms were analyzed. Only five local products and no online products are 
certified by COFEPRIS as drugs. Forty-eight percent of the formulations are monostrain 
and the rest are multistrain. Seventy-two percent of the formulations are probiotics and the 
rest are synbiotics. Among the 61 products analyzed, 46 species belonging to 13 different 
genera were identified, and 39% were common to local and online products. Many of 
products contain species of the Lactobacillus and Bifidobacterium genera. The genus 
Bacillus was the only genus that was never combined with other genera in the formulations 
analyzed in this study.
Conclusions: The population of the state of Tabasco can find at least 31 formulations 
of probiotics in local establishments. The variety increases if we consider the dietary 
supplements available for sale online. Multistrain supplements are particularly abundant 
in online retailers. The products certified by COFEPRIS ensure that the benefits of the 
formulation are supported by clinical trials in humans and are manufactured following 
good manufacturing practices.
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Resumen
Objetivo: Analizar la composición de formulaciones de probióticos que se venden en 
establecimientos del Estado de Tabasco o que se pueden comprar en línea.
Materiales y métodos: Estudio descriptivo en el que se identificaron formulaciones de 
probióticos comercializados en 21 establecimientos de la ciudad de Villahermosa y se 
compararon con 30 suplementos probióticos comercializados en línea. La información 
del producto se organizó en una base de datos y se analizó de acuerdo con la forma de 
dosificación, los géneros y especies / subespecies de probióticos presentes y su clasificación 
como probióticos o simbióticos y como medicamentos o suplementos.
Resultados: Se analizaron 31 productos locales y 30 productos de venta en línea 
formulados con probióticos en 6 formas de dosificación diferentes. Solo cinco productos 
locales y ningún producto en línea están certificados por COFEPRIS como medicamentos. 
El 48%  de las formulaciones son monocepa y el resto son multicepa. El 72% de 
las formulaciones son probióticos y el resto son simbióticos. Entre los 61 productos 
analizados, se identificaron 46 especies pertenecientes a 13 géneros diferentes y el 39% 
fueron comunes a productos locales y de venta en línea. Muchos de los productos contienen 
especies de los géneros Lactobacillus y Bifidobacterium. El género Bacillus fue el único 
que nunca se combinó con otros géneros en las formulaciones analizadas en este estudio .
Conclusiones: La población del estado de Tabasco puede encontrar al menos 31 
formulaciones de probióticos en establecimientos locales. La variedad aumenta si tenemos 
en cuenta los suplementos dietéticos disponibles de venta en línea. Los suplementos 
multicepa son particularmente abundantes en los productos en línea. Los productos 
certificados por COFEPRIS aseguran que los beneficios de la formulación están 
respaldados por ensayos clínicos en humanos y se fabrican siguiendo buenas prácticas de 
fabricación.
Palabras llave: Probióticos; simbióticos; suplementos dietéticos; Lactobacillus; 
Bifidobacterium.
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Introduction
According to the Scientific Association of Probiotics and 
Prebiotics (ISAPP) consensus, probiotics are defined as 
“live microorganisms which when administered in adequate 
amounts confer a health benefit”. Microorganisms must 
be well characterized, be safe, and provide a general 
benefit to humans, supported by scientific evidence, to be 
considered probiotics1. Lactobacillus, Bifidobacterium, 
and Saccharomyces species are the most commonly used 
probiotics. Other less frequently used probiotics include 
species of Bacillus, Propionibacterium, Streptococcus, and 
Escherichia2. Evidence supports that probiotics can improve 
the immune system response, gastrointestinal health, and 
vaginal lactobacilli concentration. However, they do not 
promote persistent changes in gut microbiota3.
Formulations containing probiotics must ensure an effective 
microorganism dose viable until the expiration date to be 
considered supplements and be allowed to declare a specific 
beneficial property. In addition, a risk and benefit assessment 
and the compliance with regulatory standards in each 
country are required to register the formulations as drugs1. In 
addition to probiotics, many formulations include substrates 
used selectively by host microorganisms that also confer a 
health benefit (prebiotics). This combination of probiotics 
and prebiotics is called a synbiotic4.
In Mexico, we can find formulations containing probiotics 
that have been approved by the Federal Commission for 
the Protection against Sanitary Risks (COFEPRIS, for its 
acronym in Spanish; https://www.gob.mx/cofepris) as drugs. 
Additionally, we can find formulations described as food or 
dietary supplements that, in some cases, declare the benefit 
they confer. The population should know what probiotic 
products can be purchased on the market and the differences 
among them when selecting them or recommending their 
use.
In this study, we identified formulations containing probiotics 
sold in the State of Tabasco, analyzed their composition, and 
compared them with formulations that can be purchased 
online.
Materials and methods
Identification of formulations containing probiotics sold 
in local establishments.
Nineteen pharmaceutical establishments and two health 
food stores located in Villahermosa, Tabasco were visited 
between October and November 2019, and the products 
formulated with probiotics that are offered to the population 
were identified. A total of 33 different products were 
obtained; two were discarded since no reliable information 
was found in the scientific literature or in the National Center 
for Biotechnology Information (NCBI) taxonomy database 
to support the strain declared on the label. Therefore, this 
study analyzed the information of 31 products, which we 
refer to as local products. Some of these products are of 
national manufacture, while others are imported.
Identification of formulations containing probiotics sold 
online.
An internet search was carried out using the term probiotic 
supplement, and information on 30 products that can be 
purchased online was collected. All these products are 
imported.
Information recording and data analysis.
The information on local and online products was recorded 
in a database and analyzed according to several criteria, such 
as dosage form, genera, species/subspecies of probiotics 
contained, and classification as probiotics or synbiotics and 
as drugs or supplements.
Results
It was determined which products formulated with probiotics 
are sold in 19 pharmacies and two health food stores in 
Villahermosa by asking the salesmen to identify the probiotic 
products sold by the establishment. When it was detected 
that the concept of probiotics was not familiar to the seller, 
we asked him or her about supplements or medications 
that help restore or preserve the intestinal flora (the 
colloquial term used to name the gut microbiota). On some 
occasions, the best-known probiotic genera (Lactobacillus, 
Bifidobacterium, and Saccharomyces) were named to guide 
the seller. In this way, 31 products formulated with probiotics 
were identified, hereinafter referred to as local products. 
Likewise, 30 products formulated with probiotics that can be 
purchased online (products for sale online) were identified 
and compared with those sold locally.
The establishments visited belong to large pharmaceutical 
chains that operate regionally (south-southeast of the country) 
and nationally and have branches in the 17 municipalities of 
Tabasco. In addition, several of them also offer online sales. 
Thus, we can assume that the products analyzed as local can 
be purchased in the 17 municipalities of the State of Tabasco.
Classification of the formulations as drugs or supplements
The 31 local products, along with the 30 products sold 
online, were classified as supplements or drugs using the 
label information and verifying their registration by the 
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Federal Commission for Prevention against Sanitary Risks 
(COFEPRIS) as drugs. Regarding products sold online, 
100% (30) were described on the label as a food supplement 
and contained warnings that they are not regulated by the 
FDA. In general, these products stated that they contribute 
to digestive health. On the other hand, 83.87% (26) of local 
products were food supplements, and only 16.13% (5) were 
identified as drugs figure 1, some of which specify on the 
label their functions as regulators of intestinal flora, assistants 
in the treatment of diarrhea, or both.
Dosage forms of the formulations analyzed.
Figure 2 shows the dosage forms of the local and online 
formulations analyzed. The dosage form of 83% (25) of 
the products sold online was the capsule, and the rest were 
presented as tablets, chewable tablets, or gummies. By 
contrast, the variety of dosage forms is better represented in 
local products: 32% (10) are administered in capsules, 30% 
(9) in powder, 19% (6) in tablets, and 19% (6) in suspension. 
The dosage forms common to both types of products were 
the capsule and the tablet, representing 57% and 13% of the 
total products, respectively.
Original Article Analysis of formulations of probiotics accessible in Tabasco
Figure 1. Percentage of supplements and drugs formulated with probiotics that are sold locally (31 in total)
Fuente: Elaboración propia
Figure 2. Dosage forms of the formulations analyzed (61 in total).
Fuente: Elaboración propia
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Genera and species present in the formulations analyzed.
Species belonging to 8 bacterial genera and five yeast genera 
were identified in the 61 formulations analyzed. As shown in 
figure 3, local products contain species from only six genera, 
while online products contain species from 12 genera. In 
both cases, the most represented genera were Lactobacillus 
and Bifidobacterium. Some local products [64% (20)] and 
online products [36% (11)] contain species of a single genus, 
either Bifidobacterium, Lactobacillus, Saccharomyces, or 
Bacillus (Figure 3A and 3B). Unlike local products [22% 
(7)], 47% (14) of online products contained species of 2 
genera, which, in most cases, were a mixture of Lactobacillus 
and Bifidobacterium (Figure 3A). In addition, the species 
Streptococcus thermophilus was present in 8 products. It 
is worth noting that Bacillus species were not mixed with 
species of other genera in any products. Finally, among the 
online products, there were 2 cases containing species from 
10 different genera.
Analyzing the species/subspecies present in the products 
revealed that 61% (19) of the local products contained a 
single bacterial species, and 39% (12) contained 2 to 10 
different species (Figure 3C). By contrast, 30% (9) of the 
products sold online contained a single species, while 60% 
(18) contained 2 to 10 species, and the remaining 10% (3) 
contained 18 to 31 species from 10 different genera.
Figure 4 shows the 46 species and subspecies identified in 
the formulations analyzed. Thirty-nine percent (18) were 
found both in local and in online products, whereas 7% (3) 
were only present in local products and the remaining 54% 
(25) were only found in products sold online. Lactobacillus 
was the genus with the highest abundance of species (18) 
in the formulations analyzed. Lactobacillus acidophilus, 
followed by L. rhamnosus, L. plantarum, and L. casei, were 
the most represented. In all the products, specific strains 
of each species were mentioned. Although Lactobacillus 
species diversity in online products was vast, 44% of the 
species were only present in 3% (2) or less of products.
Figure 3. The Venn-Euler diagram represents the number of formulations containing species from the different genera in 
local (A) and online products (B), where the set called various genera * represents the genera Brettanomyces, Debaryomyces, 
Kluyveromyces, Torulaspora, and Leuconostoc. The number of products that contain a variable number of species/subspecies 
in their formulation (C).
Fuente: Elaboración propia
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The second most represented genus was Bifidobacterium, with 
seven species. It is worth pointing out that Bifidobacterium 
infantis and B. lactis are subspecies of Bifidobacterium 
longum and B. animalis, respectively. However, they were 
described with the old classification due to the importance 
of subspecies in studying and using probiotics. B. infantis is 
the most abundant subspecies in the infant gut microbiota, 
and B. lactis was discovered in dairy products and has been 
widely used in their production. The Bifidobacteria species 
most represented in local products were different from those 
most represented in the products sold online. In addition, 
the number of products sold online containing the most 
represented species [B. lactis (53% (16)), B. bifidum (40% 
(12)), and B. longum (33% (10))] was elevated compared to 
the Bifidobacteria species most represented in local products 
[B. infantis (13% (4)) and B. lactis (10% (3))]. Few products 
mentioned specific strains of Bifidobacteria.
The third-most abundant species were yeasts of the genus 
Saccharomyces (5), and only Saccharomyces boulardii 
was common to local and online products. Most of the 
remaining genera (7) were represented by a single species. S. 
Figure 4. Species abundance in the probiotic products analyzed. The total number of species  
in local products was 21, and the total number of species in online products was 43
Fuente: Elaboración propia
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thermophilus stood out for being the ninth most represented 
species in all of the products, preceded only by Bifidobacteria 
and Lactobacillus species.
It should be noted that Bacillus coagulans was formerly 
named Lactobacillus sporogenes5, and this name is preserved 
on product labels.
Classification of formulations as probiotics or synbiotics
The 61 formulations analyzed were classified as probiotics 
or synbiotics using the nutritional information, the list 
of ingredients declared on the label, or both figure 5. 
For this, a synbiotic was considered a mixture containing live 
microorganisms and substrate(s) used selectively by the host 
microorganisms that confer a health benefit, according to 
the consensus reported by Swanson in 2020. The substrates 
mentioned in the labels that allowed classifying the products 
as synbiotics were inulin, fructooligosaccharides, and 
oligofructose. It was observed that 32% and 23% of local 
products and online products, respectively, were synbiotic, 
even though some were declared as probiotics on the label.
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The results show that the Tabasco population has access 
to various supplements and drugs made with probiotics 
sold by local establishments. Additionally, more complex 
formulations than those sold locally can be purchased online. 
It should be noted that only 5 of the 31 local products are 
registered as drugs by COFEPRIS figure 1. Three of those 
products contain only Bacillus claussi and are administered in 
suspension (2) and capsule form (1). The other two products 
are administered in powder form, with one composed of 
Saccharomyces boulardii and the other composed of a mix 
of Lactobacillus fermentum and L. delbrueckii. Interestingly, 
none of the species contained in these drugs was one of the 
most represented in the 61 formulations analyzed (Figure 
4). Multiple studies have demonstrated the effectiveness 
of B. claussi in the treatment of acute diarrhea in children6 
and S. boulardii in reducing the risk of acquiring antibiotic-
associated diarrhea in children and adults7.
Regulatory approaches in some countries, such as Canada 
and Italy, agree that products must have a minimum amount 
of 1 x 109 CFU of well-studied microbial species per 
serving to be considered probiotic foods or supplements1. 
Health Canada lists the following as probiotic species: 
Bifidobacterium adolescentis, B. animalis subsp. animalis 
and lactis, B. bifidum, B. breve, B. longum subsp. longum and 
infantis, L. acidophilus, L. casei, L. fermentum, L. gasseri, 
L. johnsonii, L. paracasei, L. plantarum, L. rhamnosus, 
and L. salivarius. Except for L. johnsonii, all these strains 
were present in at least one formulation that we analyzed 
(Figure 4). The number of microorganisms declared in the 
five drugs identified in 64% (17) of local supplements (25) 
and all products sold online (30) is above 1 x 109 CFU, 
although some products clarify that this is the amount when 
manufactured and that the effective number of bacteria until 
the expiration date is 1 x 107 CFU.
The most commonly used dosage form was the capsule, 
followed by the tablet figure 2. However, 4 of the five drugs 
were in powder or suspension form. The strain and the dosage 
form are critical to ensure that the probiotics remain viable 
since, after being ingested, the probiotic faces various fluids 
(bile salts, pancreatic enzymes, gastric juice, among others) 
during its passage through the gastrointestinal tract8. In 
addition, during encapsulation, factors such as pH, pressure, 
temperature, moisture content, amount of oxygen, and water 
activity affect the viability of microorganisms9. Improper 
storage or distribution of these products, or both, can also 
affect the viability of the microorganisms. Notably, several 
studies show that probiotics that have been killed, destroyed 
by heat, or inactivated by ultraviolet light, and even cellular 
Figure 5. Classification of the analyzed products (61 in total) as probiotics or synbiotics
Fuente: Elaboración propia
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fractions, can confer health benefits and be as effective as 
living organisms and, in some instances, safer for the host in 
the treatment of some conditions10,11.
Regarding the complexity of the formulations analyzed, 46% 
(28) contained only one probiotic strain of the Lactobacillus, 
Bifidobacterium, Saccharomyces, or Bacillus genera, so 
they were considered monostrains. In contrast, the rest of 
the formulations were multistrain and contained two to 32 
species from 14 different genera figure 3. The abundance 
of species of the genera Lactobacillus and Bifidobacterium 
is evident. These species have been widely studied with 
favorable results in multiple gastrointestinal tract disorders, 
such as irritable bowel syndrome, ulcerative colitis, Crohn’s 
disease, and infectious and antibiotic-associated traveler’s 
diarrhea12. The strain included is essential when choosing 
probiotic formulations for the treatment of gastrointestinal 
diseases. L. acidophilus LB is effective in the treatment of 
traveler’s diarrhea, while other L. acidophilus strains are 
not13. For this reason, the strain must be specified in the 
formulations.
Although monostrain products are the most studied, the 
efficacy of multistrain formulations in treating different 
conditions is being increasingly studied. For example, a 
probiotic composed of 4 strains of Lactobacillus (3) and 
Enterococcus (1) species was well tolerated and associated 
with a decrease in intestinal inflammation in patients with 
ulcerative colitis14. Likewise, a synbiotic formulation 
composed of fructooligosaccharides and six strains of 
Lactobacillus (4), Bifidobacterium (1), and Bacillus (1) 
genera significantly improved glycemic control in subjects 
with type 2 diabetes mellitus15. Another formulation with 
eight strains of Lactobacillus (4), Bifidobacterium (2), and 
Lactococcus (2) genera given to patients with type 2 diabetes 
mellitus for six months without prior medication significantly 
decreased the HOMA-IR index, reduced inflammation, 
and improved the cardiometabolic profile of patients16. 
These findings show that these types of formulations may 
be a promising adjuvant in antidiabetic therapy. Treating 
diseases is not the only benefit that can be obtained from 
ingesting multistrain formulations. The administration 
of a probiotic composed of 4 strains of Lactobacillus (3) 
and Saccharomyces (1) species reduced the toxicity of 
a mixture of phthalates and bisphenol A in Wistar17 rats, 
and very recently, a probiotic formulation of 8 strains of 
Lactobacillus (4), Bifidobacterium (3) and Streptococcus (1) 
genera cultivated in consortium from in vitro studies showed 
that it could absorb toxic elements such as Cd, Hg, and Pb. 
Additionally, the concentration of Cd in the feces of 15-day-
old infants whose mothers consumed this formulation was 
significantly reduced18. These findings open the possibility 
of using probiotic consortiums as a method for bioprotection 
and detoxification of different pollutants. On the other hand, 
the addition of different probiotic strains could also be 
considered a technological strategy. Lactococcus lactis and S. 
thermophilus were present in some of the products analyzed, 
always combined with Lactobacillus and Bifidobacteria. L. 
lactis and S. thermophilus have shown to assist the survival 
of other lactic acid bacteria in food products19. In addition, S. 
thermophilus has high oxygen consumption, so it is added to 
anaerobic microorganisms to reduce the oxygen considered 
toxic during encapsulation, avoiding affecting the viability 
of the microorganisms9. It has been shown that L. rhamnosus 
GG, the second most represented species in the products 
analyzed, promotes interactions between crucial elements 
of the microbiota, such as Bifidobacteria and the host 
epithelium, and significantly modifies the microbiota of 
healthy individuals20. These properties make it attractive for 
the formulation of both single and multistrain products.
Among the formulations analyzed, 2 contained 32 species 
of 10 different genera. The yeasts Brettanomyces anomalus, 
Debaryomyces hansenii, Kluyveromyces marxianus, and 
Torulaspora delbrueckii, and the four species of Leuconostoc 
were exclusive to these products. These yeasts have been 
identified and used as starters for various dairy products21, 
whereas various species of Leuconostoc have been identified 
in various fermented products and have shown to inhibit 
pathogen growth22. In addition to the probiotic strains, these 
formulations contain some vitamins, minerals, and enzymes 
that promote digestion. It is important to note that more is 
not always better. Therefore, it is important to have trials that 
show that a complex formulation promotes a more significant 
benefit to consumer health.
Finally, 28% of the products analyzed figure 5 were classified 
as synbiotic since their components include some prebiotic 
carbohydrates such as inulin, fructooligosaccharides, and 
oligofructose. These products are complementary synbiotics 
since the selective use of prebiotics by autochthonous 
microbiota has already been established. There are no 
studies that show that the addition of prebiotics to probiotic 
formulations leads to a more significant benefit to be 
considered synergistic synbiotics4.
Evidence supporting the benefits conferred by living, dead, 
or remnants of probiotics, as well as discrepancies in the 
effectiveness of monostrain and multistrain probiotics in 
the treatment of several conditions, reinforces the need to 
have well-characterized formulations supported by in vitro, 
preclinical and clinical trials to ensure that a formulation is 
effective to promote health or to assist in the treatment of 
specific conditions11. In addition, scientific evidence should 
support that more than one strain, additional ingredients, 
or both in the same formulation provides more significant 
benefits. In this sense, probiotics registered as drugs by 
regulatory agencies such as COFEPRIS in Mexico are safer 
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since this agency certifies that the formulations are supported 
by clinical trials in humans that prove their benefits and 
certifies that they have been prepared following good 
manufacturing practices. The comparison between local 
and online products shows that although online products 
widen the variety of formulations that we can purchase, they 
are marketed in Mexico and abroad following regulations 
different from those that govern drugs; therefore, they are 
not required to support the expected benefits with scientific 
evidence, and consequently, there is no obligation to mention 
the benefits on the label.
Conclusions
The population of the state of Tabasco can find at least 31 
formulations containing probiotics. The variety of products 
increases if the supplements that can be purchased for sale 
online are considered, particularly with regard to multistrain 
supplements. Moreover, online product offerings increase 
and change quickly. Our findings show that probiotic 
products that can be purchased in stores and online are not 
governed by the same health regulations as those found 
locally. Considering that they are designed with living 
organisms and that many of their characteristics depend 
on their viability, health regulations must be reviewed and 
include aspects that guarantee their quality, especially those 
declared as supplements. On the other hand, we must not 
forget that the distribution of any product for sale online 
does not reach all places, and it is still necessary to have 
the products available in local establishments. A more in-
depth exploration of the local market over time will allow 
an understanding of if the formulations offered increase 
and diversify. In addition, exploring the use of probiotics 
in local clinical practice would be useful to determine if 
health professionals demand a greater diversity of these 
products and if they have pertinent information about them 
to prescribe and recommend them.
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Appendix 1. Local and online products included in this study.







Enterogermina (Sanofi)* Suspension Align Probiotic (Align) Capsule
Sinuberase (Laboratoire Unither)* Suspension Align Digestive Care Probiotic (Align) Capsule
Sinuberase (Laboratoire Unither)* Capsule Align Fuerza Extra (Align) Capsule
Lacteol fort (Carnot)* Powder Kids daily probiotic (Culturelle) C h e w a b l e 
tablet
Floratil (Biocodex 1)* Powder Digestive Health Extra Strength (Culturelle) C h e w a b l e 
tablet
Esporas de Bacillus claussi (Laboratoire 
Unither)
Suspension Probiotix complex (GNC) Capsule
Lactipan baby (Italmex pharma) Suspension Ultra 50 Probiotic Complex (GNC) Capsule
Lactipan Kids (Italmex pharma) Suspension Probiotix (GNC) Capsule
Lactipan (Italmex pharma) Powder Probiotic solutions with enzymes (GNC) Capsule
Simi bacilos forte (Manufacturas Naturex) Capsule RAW probiotics women (Garden of life) Capsule
Simi probacilus (Manufacturas Naturex) Tablet RAW probiotics colon care (Garden of life) Capsule
Simi Próbioticos (Laboratorios Vimex) Powder Ultimate cultures complex (Mayfair 
nutrition)
Capsule
Simi Próbioticos (Manufacturas Naturex) Tablet Mycrobiome probiotic (Mayfair nutrition) Capsule
Protectis (TwoPac AB) Suspension Alkabiotics 7 probioticos (Alka balance) Capsule
Lactobacillus (Manufacturas Naturex) Capsule PRO-Moms (Hyperbiotics) Tablet
Bioflavonoides, Lactobacillus y vitamina C 
(Manufacturas Naturex)
Tablet PB8 probiotic (PB8) Capsule
Zulik (Manufacturas Naturex) Tablet 4-strain probiotic (Walgreens) Capsule
Lactiv sp (Manufacturas Naturex) Tablet Probiotic (Walgreens) Capsule
Lactiv kids (Manufacturas Naturex) Tablet Probiotic with Sacharomyces boulardii 
(Walgreens)
Capsule
Lactiv kids (Manufacturas Naturex) Powder Super Probiotic (Walgreens) Capsule
Lactiv inulina y probióticos (Manufacturas 
Naturex)
Powder Daily probiotic (Walgreens) Capsule
Lactobacilos (Gelpharma) Capsule Probiotic gummies (Walgreens) Gummy
Proviover (Manufacturas Naturex) Capsule Nighttime probiotic (Walgreens) Capsule
Probilog IBS (Laboratoires Mayoly splinder) Powder Daytime probiotic (Walgreens) Capsule
Glutapak R (Victus) Powder Ultimate probiotic (Walgreens) Capsule
Probiomax (Natutech) Capsule Fiber and probiotic (Walgreens) Capsule
Vivera (Probiotical) Powder Mature adult probiotic (Walgreens) Capsule
Probiotic complex (GNC) Capsule Children´s probiotic chewable tablets whit 
lactobacillus rhamnosus GG (Walgreens)
Tablet
Probiotix (Bioleven) Capsule Women´s probiotic (Walgreens) Capsule
D- Galac (Biomiral) Capsule Probiotic colon support (Walgreens) Capsule
Proteflor (Siegfried Rhein) Capsule
* Products registered by COFEPRIS.
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